INR 78.05
(-4.33%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 243.89 Million INR | 6.39% |
2022 | 229.23 Million INR | 153.5% |
2021 | 90.42 Million INR | -42.72% |
2020 | 157.86 Million INR | 423.13% |
2019 | 30.17 Million INR | -93.47% |
2018 | 462.27 Million INR | -0.67% |
2017 | 465.4 Million INR | -43.51% |
2016 | 823.83 Million INR | 2.37% |
2015 | 804.79 Million INR | 17.22% |
2014 | 686.54 Million INR | -36.56% |
2013 | 1.08 Billion INR | 8.02% |
2012 | 1 Billion INR | 280.49% |
2011 | 263.3 Million INR | -48.42% |
2010 | 510.47 Million INR | 71.33% |
2009 | 297.94 Million INR | 24.65% |
2008 | 239.02 Million INR | -3.59% |
2007 | 247.92 Million INR | 44.89% |
2006 | 171.11 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 165.85 Million INR | 0.0% |
2023 FY | 243.89 Million INR | 6.39% |
2023 Q4 | 243.89 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q4 | 229.23 Million INR | 0.0% |
2022 FY | 229.23 Million INR | 153.5% |
2022 Q2 | 199.92 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2021 Q2 | 30.45 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 90.42 Million INR | 0.0% |
2021 FY | 90.42 Million INR | -42.72% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 35.46 Million INR | 0.0% |
2020 FY | 157.86 Million INR | 423.13% |
2020 Q4 | 157.86 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 30.17 Million INR | -93.47% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 469.97 Million INR | 0.0% |
2019 Q4 | 30.17 Million INR | 0.0% |
2018 FY | 462.27 Million INR | -0.67% |
2018 Q4 | 462.27 Million INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2017 FY | 465.4 Million INR | -43.51% |
2016 FY | 823.83 Million INR | 2.37% |
2015 FY | 804.79 Million INR | 17.22% |
2014 FY | 686.54 Million INR | -36.56% |
2013 FY | 1.08 Billion INR | 8.02% |
2012 FY | 1 Billion INR | 280.49% |
2012 Q2 | 491.39 Million INR | 0.0% |
2012 Q4 | 1 Billion INR | 0.0% |
2011 FY | 263.3 Million INR | -48.42% |
2010 FY | 510.47 Million INR | 71.33% |
2009 FY | 297.94 Million INR | 24.65% |
2008 FY | 239.02 Million INR | -3.59% |
2007 FY | 247.92 Million INR | 44.89% |
2006 FY | 171.11 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 82.951% |
Ind-Swift Limited | 10.13 Billion INR | 97.595% |
Bajaj HealthCare Limited | 3.32 Billion INR | 92.672% |
Sakar Healthcare Limited | 793.51 Million INR | 69.264% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.633% |
Innova Captab Limited | 2.45 Billion INR | 90.049% |
Divi's Laboratories Limited | 30 Million INR | -712.977% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -430.41% |
Morepen Laboratories Limited | 289.99 Million INR | 15.897% |
Mankind Pharma Limited | 2.07 Billion INR | 88.228% |
Sequent Scientific Limited | 4.87 Billion INR | 94.999% |
Wanbury Limited | 1.16 Billion INR | 79.062% |
Laurus Labs Limited | 25.77 Billion INR | 99.054% |
Nectar Lifesciences Limited | 6.35 Billion INR | 96.162% |
Glenmark Life Sciences Limited | 171.48 Million INR | -42.228% |
Alembic Limited | 91.5 Million INR | -166.55% |
Hikal Limited | 8.17 Billion INR | 97.017% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 95.247% |
Neuland Laboratories Limited | 953.89 Million INR | 74.432% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 93.542% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 98.019% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 25.552% |
Themis Medicare Limited | 957.92 Million INR | 74.539% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 96.967% |
Lupin Limited | 29.21 Billion INR | 99.165% |
Amrutanjan Health Care Limited | 17.28 Million INR | -1311.173% |
Wockhardt Limited | 23.56 Billion INR | 98.965% |
Vaishali Pharma Limited | 134.91 Million INR | -80.771% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 91.45% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -172.78% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.334% |
FDC Limited | 205.18 Million INR | -18.865% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 98.782% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 22.932% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.123% |
Venus Remedies Limited | 413.3 Million INR | 40.989% |
ZIM Laboratories Limited | 1.08 Billion INR | 77.588% |
Bliss GVS Pharma Limited | 998.4 Million INR | 75.572% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | -1138.036% |
Shilpa Medicare Limited | 9.37 Billion INR | 97.398% |
Albert David Limited | 33.24 Million INR | -633.689% |
Ajanta Pharma Limited | 352.8 Million INR | 30.869% |
Hester Biosciences Limited | 2.44 Billion INR | 90.02% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 62.476% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 97.589% |
Gufic Biosciences Limited | 3.32 Billion INR | 92.674% |
Windlas Biotech Limited | 36.41 Million INR | -569.852% |
Procter & Gamble Health Limited | 95.6 Million INR | -155.118% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 22.209% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 75.237% |
Granules India Limited | 13.15 Billion INR | 98.145% |
Aarti Drugs Limited | 5.64 Billion INR | 95.678% |
Bal Pharma Limited | 1.39 Billion INR | 82.535% |
Alkem Laboratories Limited | 14.18 Billion INR | 98.281% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.255% |
Lincoln Pharmaceuticals Limited | 10.66 Million INR | -2186.211% |
Medicamen Biotech Limited | 308.17 Million INR | 20.858% |
Unichem Laboratories Limited | 2.47 Billion INR | 90.146% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -5456.915% |
Valiant Laboratories Limited | 767.08 Million INR | 68.205% |
Orchid Pharma Limited | 1.35 Billion INR | 81.958% |
Medico Remedies Limited | 80.5 Million INR | -202.958% |
Ind-Swift Laboratories Limited | 166.21 Million INR | -46.733% |
Ipca Laboratories Limited | 14.38 Billion INR | 98.304% |
Brooks Laboratories Limited | 56.41 Million INR | -332.289% |
Syncom Formulations (India) Limited | 724.86 Million INR | 66.353% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.954% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.394% |
NATCO Pharma Limited | 3.71 Billion INR | 93.43% |
Suven Life Sciences Limited | 7.09 Million INR | -3336.565% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 87.391% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.031% |
Indoco Remedies Limited | 6.71 Billion INR | 96.37% |
Alpa Laboratories Limited | 52.46 Million INR | -364.868% |
Lasa Supergenerics Limited | 220.76 Million INR | -10.478% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 60.116% |